How should we monitor patients with acute respiratory failure treated with noninvasive ventilation?

Eur Respir Rev. 2018 Apr 13;27(148):170101. doi: 10.1183/16000617.0101-2017. Print 2018 Jun 30.

Abstract

Noninvasive ventilation (NIV) is currently one of the most commonly used support methods in hypoxaemic and hypercapnic acute respiratory failure (ARF). With advancing technology and increasing experience, not only are indications for NIV getting broader, but more severe patients are treated with NIV. Depending on disease type and clinical status, NIV can be applied both in the general ward and in high-dependency/intensive care unit settings with different environmental opportunities. However, it is important to remember that patients with ARF are always very fragile with possible high mortality risk. The delay in recognition of unresponsiveness to NIV, progression of respiratory failure or new-onset complications may result in devastating and fatal outcomes. Therefore, it is crucial to understand that timely action taken according to monitoring variables is one of the key elements for NIV success. The purpose of this review is to outline basic and advanced monitoring techniques for NIV during an ARF episode.

Publication types

  • Review

MeSH terms

  • Acute Disease
  • Cardiovascular System / physiopathology
  • Cause of Death
  • Critical Care
  • Disease Progression
  • Health Status
  • Humans
  • Lung / physiopathology*
  • Monitoring, Physiologic / methods*
  • Noninvasive Ventilation / adverse effects
  • Noninvasive Ventilation / methods*
  • Predictive Value of Tests
  • Respiration*
  • Respiratory Function Tests*
  • Respiratory Insufficiency / diagnosis
  • Respiratory Insufficiency / mortality
  • Respiratory Insufficiency / physiopathology
  • Respiratory Insufficiency / therapy*
  • Risk Factors
  • Sleep
  • Treatment Failure